-
1
-
-
84948792353
-
-
[Internet. Accessed September 8]
-
Langford CA. Granulomatosis with polyangiitis (Wegener's). [Internet. Accessed September 8, 2015.] Available from: www.rheumatology.org/Practice/Clinical/Patients/Diseases-And-C onditions/Granulomatosis-with-Polyangiitis-%28Wegener-s%29/
-
(2015)
Granulomatosis with Polyangiitis (wegener'S)
-
-
Langford, C.A.1
-
2
-
-
84905502868
-
Key advances in the clinical approach to ANCA-associated vasculitis
-
Kallenberg CG. Key advances in the clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol 2014;10:484-93.
-
(2014)
Nat Rev Rheumatol
, vol.10
, pp. 484-493
-
-
Kallenberg, C.G.1
-
3
-
-
84871251698
-
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
-
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11.
-
(2013)
Arthritis Rheum
, vol.65
, pp. 1-11
-
-
Jennette, J.C.1
Falk, R.J.2
Bacon, P.A.3
Basu, N.4
Cid, M.C.5
Ferrario, F.6
-
4
-
-
79951518112
-
Long-term patient survival in ANCA-associated vasculitis
-
Flossman O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 2011;70:488-94.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 488-494
-
-
Flossman, O.1
Berden, A.2
De Groot, K.3
Hagen, C.4
Harper, L.5
Heijl, C.6
-
5
-
-
66949130345
-
Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: Two diseases or one 'anti-neutrophil cytoplasm antibodies-associated vasculitis' entity?
-
Mahr AD. Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: two diseases or one 'anti-neutrophil cytoplasm antibodies-associated vasculitis' entity? APMIS 2009;117:14-47.
-
(2009)
APMIS
, vol.117
, pp. 14-47
-
-
Mahr, A.D.1
-
6
-
-
33745682189
-
Case control study of ANCA associated vasculitis in western Montana
-
Zeft AS, Weiss N. Case control study of ANCA associated vasculitis in western Montana. Arthritis Rheum 2005;52:S648.
-
(2005)
Arthritis Rheum
, vol.52
, pp. S648
-
-
Zeft, A.S.1
Weiss, N.2
-
7
-
-
0035053927
-
A disease-specific activity index for Wegener's granulomatosis
-
Stone JH, Hoffman GS, Merkel PA, Min Y, Uhlfelder ML, Hellmann DB, et al. A disease-specific activity index for Wegener's granulomatosis. Arthritis Rheum 2001;44:912-20.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 912-920
-
-
Stone, J.H.1
Hoffman, G.S.2
Merkel, P.A.3
Min, Y.4
Uhlfelder, M.L.5
Hellmann, D.B.6
-
8
-
-
84928957372
-
BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis
-
Ntatsaki E, Carruthers D, Chakravarty K, D'Cruz D, Harper L, Jayne D, et al. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology 2014;53:2306-9.
-
(2014)
Rheumatology
, vol.53
, pp. 2306-2309
-
-
Ntatsaki, E.1
Carruthers, D.2
Chakravarty, K.3
D'Cruz, D.4
Harper, L.5
Jayne, D.6
-
9
-
-
84899697025
-
Current and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)
-
Tarzi RM, Pusey CD. Current and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis). Ther Clin Risk Manag 2014;2014:279-93.
-
(2014)
Ther Clin Risk Manag
, vol.2014
, pp. 279-293
-
-
Tarzi, R.M.1
Pusey, C.D.2
-
10
-
-
34547799013
-
Treatment of antineutrophil cytoplasmic antibody-associated vasculitis
-
Bosch X, Guilabert A, Espinosa G, Mirapeix E. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis. JAMA 2007;298:655-69.
-
(2007)
JAMA
, vol.298
, pp. 655-669
-
-
Bosch, X.1
Guilabert, A.2
Espinosa, G.3
Mirapeix, E.4
-
11
-
-
77954651554
-
Rituximab versus cyclophosphamide for ANCA-associated vasculitis
-
Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010;2010:221-32.
-
(2010)
N Engl J Med
, vol.2010
, pp. 221-232
-
-
Stone, J.H.1
Merkel, P.A.2
Spiera, R.3
Seo, P.4
Langford, C.A.5
Hoffman, G.S.6
-
12
-
-
84948752176
-
-
South San Francisco, CA: Genentech Inc
-
Rituximab package insert. South San Francisco, CA: Genentech Inc.; 2014.
-
(2014)
Rituximab Package Insert
-
-
-
13
-
-
0037227218
-
Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis
-
Koldingsnes W, Nossent JC. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis. J Rheumatol 2003;30:80-8.
-
(2003)
J Rheumatol
, vol.30
, pp. 80-88
-
-
Koldingsnes, W.1
Nossent, J.C.2
-
14
-
-
27644437166
-
Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessell vasculitis
-
Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessell vasculitis. Ann Intern Med 2005;143:621-31.
-
(2005)
Ann Intern Med
, vol.143
, pp. 621-631
-
-
Hogan, S.L.1
Falk, R.J.2
Chin, H.3
Cai, J.4
Jennette, C.E.5
Jennette, J.C.6
-
15
-
-
51849091965
-
Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: Comparison of two independent cohorts
-
Pagnoux C, Hogan SL, Chin H, Jennette CE, Falk RJ, Guillevin L, et al. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts. Arthritis Rheum 2008;58:2908-18.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 2908-2918
-
-
Pagnoux, C.1
Hogan, S.L.2
Chin, H.3
Jennette, C.E.4
Falk, R.J.5
Guillevin, L.6
-
16
-
-
78650784897
-
Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades
-
Holle JU, Gross WL, Latza U, Nolle B, Ambrosch P, Heller M, et al. Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 2011;63:257-66.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 257-266
-
-
Holle, J.U.1
Gross, W.L.2
Latza, U.3
Nolle, B.4
Ambrosch, P.5
Heller, M.6
-
18
-
-
0026639706
-
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
-
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
-
(1992)
J Clin Epidemiol
, vol.45
, pp. 613-619
-
-
Deyo, R.A.1
Cherkin, D.C.2
Ciol, M.A.3
-
19
-
-
0348111413
-
Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis
-
Koutantji M, Harrold E, Lane SE, Pearce S, Watts RA, Scott DG. Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum 2003; 49:826-37.
-
(2003)
Arthritis Rheum
, vol.49
, pp. 826-837
-
-
Koutantji, M.1
Harrold, E.2
Lane, S.E.3
Pearce, S.4
Watts, R.A.5
Scott, D.G.6
-
20
-
-
62549137799
-
Health-related quality of life for patients with vasculitis and their spouses
-
Carpenter DM, Thorpe CT, Lewis M, Devellis RF, Hogan SL. Health-related quality of life for patients with vasculitis and their spouses. Arthritis Rheum 2009;61:259-65.
-
(2009)
Arthritis Rheum
, vol.61
, pp. 259-265
-
-
Carpenter, D.M.1
Thorpe, C.T.2
Lewis, M.3
Devellis, R.F.4
Hogan, S.L.5
-
21
-
-
0034743343
-
Self-assessed physical and mental function of haemodialysis patients
-
Mittal SK, Ahern L, Flaster E, Maesaka JK, Fishbane S. Self-assessed physical and mental function of haemodialysis patients. Nephrol Dial Transplant 2001;16:1387-94.
-
(2001)
Nephrol Dial Transplant
, vol.16
, pp. 1387-1394
-
-
Mittal, S.K.1
Ahern, L.2
Flaster, E.3
Maesaka, J.K.4
Fishbane, S.5
-
22
-
-
0037097578
-
Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis
-
Reinhold-Keller E, Herlyn K, Wagner-Bastmever R, Gutfleisch J, Peter HH, Raspe HH, et al. Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis. Arthritis Rheum 2002;47:320-5.
-
(2002)
Arthritis Rheum
, vol.47
, pp. 320-325
-
-
Reinhold-Keller, E.1
Herlyn, K.2
Wagner-Bastmever, R.3
Gutfleisch, J.4
Peter, H.H.5
Raspe, H.H.6
-
23
-
-
0030042974
-
The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources
-
Cotch M, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA. The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996;39:87-92.
-
(1996)
Arthritis Rheum
, vol.39
, pp. 87-92
-
-
Cotch, M.1
Hoffman, G.S.2
Yerg, D.E.3
Kaufman, G.I.4
Targonski, P.5
Kaslow, R.A.6
-
24
-
-
4243896778
-
The prevalence, epidemiology and cost of hospitalizations for vasculitis in New York State 1986 to 1990 [abstract]
-
Cotch MF, Hoffman GS. The prevalence, epidemiology and cost of hospitalizations for vasculitis in New York State 1986 to 1990 [abstract]. Arthritis Rheum 1995;38:S225.
-
(1995)
Arthritis Rheum
, vol.38
, pp. S225
-
-
Cotch, M.F.1
Hoffman, G.S.2
|